Replies to post #26934 on Applied DNA Sciences Inc (APDN)

[Shail]

Just went thru the conference call transcript.

The expenses of 17.6 mn look staggering. All though about 10 mn are non-cash, how many will read thru and understand the concept.

Also, how does the 7.8 mn of cash expenses compare with last year. Also, if non-cash expenses are related to the share price, due to the warrants, will there be an advantage in keeping the share price low?????

Whatever be the explanation, 17.6 mn as expenses against a revenue of 2 mn seems too lop-sided. They should have been able to present this in a different way. The CFO talks of control over expenses - Where do we see that???

Also did not see any mention of the MDA project. What is the status of that - Did the Dr explain??

Somehow despite the potential, I think APDN has failed to present a good financial picture.